TransMedics Group, Inc. (TMDX) — Fair Value Analysis

Base-case fair value (P50): $72.90 · Current price: $67.79 · Verdict: Fairly Valued

The Verdict on TMDX

TRANSMEDICS GROUP INC (TMDX) appears fairly valued by our Monte Carlo simulations, with a median fair value (P50) of $72.90 suggesting a +7.5% upside from its current trading price of $67.79. This assessment, derived from thousands of forward-looking scenarios, indicates that TMDX's present valuation aligns closely with its intrinsic worth given prevailing market conditions and company fundamentals. Our analysis places TMDX's current price point as reasonably reflective of its underlying value based on the aggregated probabilities generated by our models.

How TMDX stacks up against peers

Our analysis places TMDX in an average quality tier, reflecting its operational and financial health relative to its sector peers. While not exceptional, this average standing supports the Monte Carlo simulation's median fair value (P50) of $72.90. A company at this quality tier, trading at $67.79, typically doesn't present significant overvaluation or undervaluation without substantial shifts in its underlying business performance or market sentiment. The modest +7.5% potential upside from the current price further corroborates this 'fairly valued' assessment.

What this means for investors

For investors, TMDX's status as fairly valued at its $67.79 price point, with a median fair value of $72.90, suggests that significant alpha generation from a simple 'buy low, sell high' strategy based on current valuation alone may be challenging. While the +7.5% gap implies some room for appreciation, this is within a reasonable margin for a company rated as average quality. Downside scenarios, though not quantified here, are always a consideration, as are potential bull cases. FairCurve subscribers gain access to the full probabilistic distribution. Sign up for a free FairCurve account to see the full bear/bull distribution and track TMDX's fair value as new fundamentals are released.